Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - Cerevel Therapeutics Holdings, Inc. | d87562dex232.htm |
| EX-21.1 - EX-21.1 - Cerevel Therapeutics Holdings, Inc. | d87562dex211.htm |
| EX-5.1 - EX-5.1 - Cerevel Therapeutics Holdings, Inc. | d87562dex51.htm |
| S-1 - S-1 - Cerevel Therapeutics Holdings, Inc. | d87562ds1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Registration Statement of Cerevel Therapeutics Holdings, Inc. on Form S-1, of our report dated August 5, 2020, relating to the balance sheet of ARYA Sciences Acquisition Corp II as of June 9, 2020, and the related statements of operations, changes in shareholders’ equity and cash flows for the period from February 20, 2020 (inception) through June 9, 2020, and to the reference to our Firm under the caption “Experts” in the Registration Statement.
/s/ WithumSmith+Brown, PC
New York, New York
November 25, 2020